AU612589B2 - Nasal pharmaceutical composition containing a somatostatin analogue - Google Patents
Nasal pharmaceutical composition containing a somatostatin analogueInfo
- Publication number
- AU612589B2 AU612589B2 AU77120/87A AU7712087A AU612589B2 AU 612589 B2 AU612589 B2 AU 612589B2 AU 77120/87 A AU77120/87 A AU 77120/87A AU 7712087 A AU7712087 A AU 7712087A AU 612589 B2 AU612589 B2 AU 612589B2
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- composition containing
- somatostatin analogue
- nasal pharmaceutical
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868620035A GB8620035D0 (en) | 1986-08-18 | 1986-08-18 | Organic compounds |
GB8620035 | 1986-08-18 | ||
GB8626821 | 1986-11-10 | ||
GB868626821A GB8626821D0 (en) | 1986-11-10 | 1986-11-10 | Organic compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU85689/91A Division AU637530B2 (en) | 1986-08-18 | 1991-10-09 | Novel galenical formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7712087A AU7712087A (en) | 1988-02-25 |
AU612589B2 true AU612589B2 (en) | 1991-07-18 |
Family
ID=26291187
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77120/87A Ceased AU612589B2 (en) | 1986-08-18 | 1987-08-17 | Nasal pharmaceutical composition containing a somatostatin analogue |
AU85689/91A Ceased AU637530B2 (en) | 1986-08-18 | 1991-10-09 | Novel galenical formulations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU85689/91A Ceased AU637530B2 (en) | 1986-08-18 | 1991-10-09 | Novel galenical formulations |
Country Status (24)
Country | Link |
---|---|
KR (1) | KR880002537A (en) |
AT (1) | AT396331B (en) |
AU (2) | AU612589B2 (en) |
BE (1) | BE1001748A4 (en) |
CA (1) | CA1322331C (en) |
CH (1) | CH672252A5 (en) |
CS (1) | CS411491A3 (en) |
DE (1) | DE3726517A1 (en) |
DK (1) | DK428287A (en) |
ES (1) | ES2004807A6 (en) |
FI (1) | FI93307C (en) |
FR (1) | FR2602680B1 (en) |
GR (1) | GR871289B (en) |
HK (1) | HK80493A (en) |
HU (1) | HU200940B (en) |
IE (1) | IE60761B1 (en) |
IL (1) | IL83572A (en) |
IT (1) | IT1222510B (en) |
LU (1) | LU86971A1 (en) |
NL (1) | NL8701874A (en) |
NO (1) | NO175519C (en) |
NZ (1) | NZ221473A (en) |
PT (1) | PT85545B (en) |
SE (1) | SE8703183L (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003216084A1 (en) | 2002-01-22 | 2003-09-02 | New York University | Methods for therapeutic treatment of benign prostatic hypertrophy (bph) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6034925B2 (en) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | Long-acting nasal preparation and its manufacturing method |
CY1327A (en) * | 1979-11-27 | 1986-06-27 | Sandoz Ag | Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use |
US4451394A (en) * | 1982-10-25 | 1984-05-29 | American Home Products Corporation | Dodecapeptides preventing glucose and triglyceride assimilation |
JPS59163313A (en) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
US4505897A (en) * | 1983-04-18 | 1985-03-19 | The Administrators Of The Tulane Educational Fund | Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith |
GB8514090D0 (en) * | 1985-06-04 | 1985-07-10 | Sandoz Ltd | Organic compounds |
US4612302A (en) * | 1983-11-14 | 1986-09-16 | Brigham And Women's Hospital | Clinical use of somatostatin analogues |
JPS60224616A (en) * | 1984-04-24 | 1985-11-09 | Teijin Ltd | Composition for administration through nose |
US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
JPH085913B2 (en) * | 1985-09-12 | 1996-01-24 | ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド | Therapeutic somatostatin congeners |
-
1987
- 1987-08-08 DE DE19873726517 patent/DE3726517A1/en not_active Ceased
- 1987-08-10 NL NL8701874A patent/NL8701874A/en not_active Application Discontinuation
- 1987-08-10 HU HU873618A patent/HU200940B/en not_active IP Right Cessation
- 1987-08-10 BE BE8700893A patent/BE1001748A4/en not_active IP Right Cessation
- 1987-08-10 FR FR8711402A patent/FR2602680B1/en not_active Expired - Fee Related
- 1987-08-14 LU LU86971A patent/LU86971A1/en unknown
- 1987-08-14 CH CH3134/87A patent/CH672252A5/de not_active IP Right Cessation
- 1987-08-17 FI FI873548A patent/FI93307C/en not_active IP Right Cessation
- 1987-08-17 GR GR871289A patent/GR871289B/en unknown
- 1987-08-17 AU AU77120/87A patent/AU612589B2/en not_active Ceased
- 1987-08-17 CA CA000544704A patent/CA1322331C/en not_active Expired - Fee Related
- 1987-08-17 NO NO873452A patent/NO175519C/en unknown
- 1987-08-17 KR KR1019870008981A patent/KR880002537A/en not_active Application Discontinuation
- 1987-08-17 AT AT0206087A patent/AT396331B/en not_active IP Right Cessation
- 1987-08-17 NZ NZ221473A patent/NZ221473A/en unknown
- 1987-08-17 IL IL83572A patent/IL83572A/en not_active IP Right Cessation
- 1987-08-17 IE IE218787A patent/IE60761B1/en not_active IP Right Cessation
- 1987-08-17 DK DK428287A patent/DK428287A/en unknown
- 1987-08-17 PT PT85545A patent/PT85545B/en not_active IP Right Cessation
- 1987-08-17 SE SE8703183A patent/SE8703183L/en not_active Application Discontinuation
- 1987-08-18 ES ES8702432A patent/ES2004807A6/en not_active Expired
- 1987-08-18 IT IT21670/87A patent/IT1222510B/en active
-
1991
- 1991-10-09 AU AU85689/91A patent/AU637530B2/en not_active Ceased
- 1991-12-27 CS CS914114A patent/CS411491A3/en unknown
-
1993
- 1993-08-05 HK HK804/93A patent/HK80493A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU561463B2 (en) | A pharmaceutical formulation containing azapropazone | |
NZ215737A (en) | Intranasal pharmaceutical compositions containing insulin | |
GB2193891B (en) | Nasal pharmaceutical composition containing a somatostatin anologue. | |
IL87044A0 (en) | Pharmaceutical compositions comprising somatostatin analogues | |
GB8613284D0 (en) | Nasal pharmaceutical compositions | |
AU7336487A (en) | Pharmaceutical compositions | |
AU607451B2 (en) | Pharmaceutical compositions | |
IL90639A (en) | Neplanocin derivatives and analogs and pharmaceutical compositions containing them | |
AU7939487A (en) | Pharmaceutical compositions | |
IL87943A (en) | Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination | |
GB8628373D0 (en) | Pharmaceutical composition | |
AU612589B2 (en) | Nasal pharmaceutical composition containing a somatostatin analogue | |
AU585890B2 (en) | Pharmaceutical use of somatostatin analogues | |
AU8292987A (en) | Pharmaceutical compositions | |
GB8614189D0 (en) | Pharmaceutical composition | |
IL79195A0 (en) | Pharmaceutical compositions containing a styrylnaphthalene derivative | |
AU587505B2 (en) | Pharmaceutical compositions | |
AU3298589A (en) | New pharmaceutical composition | |
GB8621008D0 (en) | Pharmaceutical composition | |
IL79194A0 (en) | Pharmaceutical compositions containing a styrylnaphthalene derivative | |
AU7819887A (en) | Pharmaceutical composition | |
IE861461L (en) | Nasal pharmaceutical composition | |
IL83177A0 (en) | Pharmaceutical compositions containing xylometazoline | |
IL86030A0 (en) | Pharmaceutical compositions containing a certain steroid | |
GB8725539D0 (en) | Pharmaceutical composition |